Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclosporin AUC monitoring after pediatric allogeneic stem cell transplantation
NL-OMON36960Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of cyclosporine in graft-versus-host disease (GVHD), sponsored by Leiden University Medical Center. Primary endpoint: Acute graft-versus-host disease. Started Feb 2013; status: active, not recruiting.
02
Drugs
cyclosporine
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NL-OMON36960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36960.